世界の店頭(OTC)及びダイエット補助食品市場 2019年

【英語タイトル】Global Over the Counter (OTC) & Diet Supplementary Market Professional Survey Report 2019

QYResearchが出版した調査資料(QYR20FB04213)・商品コード:QYR20FB04213
・発行会社(調査会社):QYResearch
・発行日:2019年10月(※2024年版があります。お問い合わせください)
・ページ数:105
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、店頭(OTC)及びダイエット補助食品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、鎮痛剤、皮膚科製品、咳、風邪、インフルエンザ製品、ビタミンサプリメント、ミネラルサプリメント、眼科製品に、用途別には、病院、クリニックにセグメント区分し、店頭(OTC)及びダイエット補助食品の世界市場を分析しました。


・エグゼクティブ・サマリー
・店頭(OTC)及びダイエット補助食品の世界市場概要
・店頭(OTC)及びダイエット補助食品の製造コスト構成分析
・店頭(OTC)及びダイエット補助食品の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・店頭(OTC)及びダイエット補助食品の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・店頭(OTC)及びダイエット補助食品のセグメント分析(種類別)
(鎮痛剤、皮膚科製品、咳、風邪、インフルエンザ製品、ビタミンサプリメント、ミネラルサプリメント、眼科製品)
・店頭(OTC)及びダイエット補助食品のセグメント分析(用途別)
(病院、クリニック)
・店頭(OTC)及びダイエット補助食品の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Bayer AG、Merck KGaA、Novartis、Johnson & Johnson、GlaxoSmithKline、Alkem Laboratories、Teva Pharmaceutical Industries、Pfizer、Sun Pharma、Allergan)
・店頭(OTC)及びダイエット補助食品の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of disease.
The global Over the Counter (OTC) & Diet Supplementary market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Over the Counter (OTC) & Diet Supplementary volume and value at global level, regional level and company level. From a global perspective, this report represents overall Over the Counter (OTC) & Diet Supplementary market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Over the Counter (OTC) & Diet Supplementary in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Over the Counter (OTC) & Diet Supplementary manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Analgesic & pain relievers
Dermatological products
Cough, cold, and flu products
Vitamin supplements
Mineral Supplements
Ophthalmic Products

Segment by Application
Hospital
Clinic

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Over the Counter (OTC) & Diet Supplementary
1.1 Definition of Over the Counter (OTC) & Diet Supplementary
1.2 Over the Counter (OTC) & Diet Supplementary Segment by Type
1.2.1 Global Over the Counter (OTC) & Diet Supplementary Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Analgesic & pain relievers
1.2.3 Dermatological products
1.2.4 Cough, cold, and flu products
1.2.5 Vitamin supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Over the Counter (OTC) & Diet Supplementary Segment by Applications
1.3.1 Global Over the Counter (OTC) & Diet Supplementary Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Over the Counter (OTC) & Diet Supplementary Overall Market
1.4.1 Global Over the Counter (OTC) & Diet Supplementary Revenue (2014-2025)
1.4.2 Global Over the Counter (OTC) & Diet Supplementary Production (2014-2025)
1.4.3 North America Over the Counter (OTC) & Diet Supplementary Status and Prospect (2014-2025)
1.4.4 Europe Over the Counter (OTC) & Diet Supplementary Status and Prospect (2014-2025)
1.4.5 China Over the Counter (OTC) & Diet Supplementary Status and Prospect (2014-2025)
1.4.6 Japan Over the Counter (OTC) & Diet Supplementary Status and Prospect (2014-2025)
1.4.7 Southeast Asia Over the Counter (OTC) & Diet Supplementary Status and Prospect (2014-2025)
1.4.8 India Over the Counter (OTC) & Diet Supplementary Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Over the Counter (OTC) & Diet Supplementary
2.3 Manufacturing Process Analysis of Over the Counter (OTC) & Diet Supplementary
2.4 Industry Chain Structure of Over the Counter (OTC) & Diet Supplementary

3 Development and Manufacturing Plants Analysis of Over the Counter (OTC) & Diet Supplementary
3.1 Capacity and Commercial Production Date
3.2 Global Over the Counter (OTC) & Diet Supplementary Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Over the Counter (OTC) & Diet Supplementary
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Over the Counter (OTC) & Diet Supplementary Production and Capacity Analysis
4.2 Over the Counter (OTC) & Diet Supplementary Revenue Analysis
4.3 Over the Counter (OTC) & Diet Supplementary Price Analysis
4.4 Market Concentration Degree

5 Over the Counter (OTC) & Diet Supplementary Regional Market Analysis
5.1 Over the Counter (OTC) & Diet Supplementary Production by Regions
5.1.1 Global Over the Counter (OTC) & Diet Supplementary Production by Regions
5.1.2 Global Over the Counter (OTC) & Diet Supplementary Revenue by Regions
5.2 Over the Counter (OTC) & Diet Supplementary Consumption by Regions
5.3 North America Over the Counter (OTC) & Diet Supplementary Market Analysis
5.3.1 North America Over the Counter (OTC) & Diet Supplementary Production
5.3.2 North America Over the Counter (OTC) & Diet Supplementary Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Over the Counter (OTC) & Diet Supplementary Import and Export
5.4 Europe Over the Counter (OTC) & Diet Supplementary Market Analysis
5.4.1 Europe Over the Counter (OTC) & Diet Supplementary Production
5.4.2 Europe Over the Counter (OTC) & Diet Supplementary Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Over the Counter (OTC) & Diet Supplementary Import and Export
5.5 China Over the Counter (OTC) & Diet Supplementary Market Analysis
5.5.1 China Over the Counter (OTC) & Diet Supplementary Production
5.5.2 China Over the Counter (OTC) & Diet Supplementary Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Over the Counter (OTC) & Diet Supplementary Import and Export
5.6 Japan Over the Counter (OTC) & Diet Supplementary Market Analysis
5.6.1 Japan Over the Counter (OTC) & Diet Supplementary Production
5.6.2 Japan Over the Counter (OTC) & Diet Supplementary Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Over the Counter (OTC) & Diet Supplementary Import and Export
5.7 Southeast Asia Over the Counter (OTC) & Diet Supplementary Market Analysis
5.7.1 Southeast Asia Over the Counter (OTC) & Diet Supplementary Production
5.7.2 Southeast Asia Over the Counter (OTC) & Diet Supplementary Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Over the Counter (OTC) & Diet Supplementary Import and Export
5.8 India Over the Counter (OTC) & Diet Supplementary Market Analysis
5.8.1 India Over the Counter (OTC) & Diet Supplementary Production
5.8.2 India Over the Counter (OTC) & Diet Supplementary Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Over the Counter (OTC) & Diet Supplementary Import and Export

6 Over the Counter (OTC) & Diet Supplementary Segment Market Analysis (by Type)
6.1 Global Over the Counter (OTC) & Diet Supplementary Production by Type
6.2 Global Over the Counter (OTC) & Diet Supplementary Revenue by Type
6.3 Over the Counter (OTC) & Diet Supplementary Price by Type

7 Over the Counter (OTC) & Diet Supplementary Segment Market Analysis (by Application)
7.1 Global Over the Counter (OTC) & Diet Supplementary Consumption by Application
7.2 Global Over the Counter (OTC) & Diet Supplementary Consumption Market Share by Application (2014-2019)

8 Over the Counter (OTC) & Diet Supplementary Major Manufacturers Analysis
8.1 Bayer AG
8.1.1 Bayer AG Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.1.2 Bayer AG Product Introduction, Application and Specification
8.1.3 Bayer AG Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Merck KGaA
8.2.1 Merck KGaA Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.2.2 Merck KGaA Product Introduction, Application and Specification
8.2.3 Merck KGaA Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis
8.3.1 Novartis Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.3.2 Novartis Product Introduction, Application and Specification
8.3.3 Novartis Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.4.2 Johnson & Johnson Product Introduction, Application and Specification
8.4.3 Johnson & Johnson Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GlaxoSmithKline
8.5.1 GlaxoSmithKline Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.5.2 GlaxoSmithKline Product Introduction, Application and Specification
8.5.3 GlaxoSmithKline Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Alkem Laboratories
8.6.1 Alkem Laboratories Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.6.2 Alkem Laboratories Product Introduction, Application and Specification
8.6.3 Alkem Laboratories Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Teva Pharmaceutical Industries
8.7.1 Teva Pharmaceutical Industries Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.7.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
8.7.3 Teva Pharmaceutical Industries Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Pfizer
8.8.1 Pfizer Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.8.2 Pfizer Product Introduction, Application and Specification
8.8.3 Pfizer Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Sun Pharma
8.9.1 Sun Pharma Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.9.2 Sun Pharma Product Introduction, Application and Specification
8.9.3 Sun Pharma Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Allergan
8.10.1 Allergan Over the Counter (OTC) & Diet Supplementary Production Sites and Area Served
8.10.2 Allergan Product Introduction, Application and Specification
8.10.3 Allergan Over the Counter (OTC) & Diet Supplementary Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Over the Counter (OTC) & Diet Supplementary Market
9.1 Global Over the Counter (OTC) & Diet Supplementary Market Trend Analysis
9.1.1 Global Over the Counter (OTC) & Diet Supplementary Market Size (Volume and Value) Forecast 2019-2025
9.2 Over the Counter (OTC) & Diet Supplementary Regional Market Trend
9.2.1 North America Over the Counter (OTC) & Diet Supplementary Forecast 2019-2025
9.2.2 Europe Over the Counter (OTC) & Diet Supplementary Forecast 2019-2025
9.2.3 China Over the Counter (OTC) & Diet Supplementary Forecast 2019-2025
9.2.4 Japan Over the Counter (OTC) & Diet Supplementary Forecast 2019-2025
9.2.5 Southeast Asia Over the Counter (OTC) & Diet Supplementary Forecast 2019-2025
9.2.6 India Over the Counter (OTC) & Diet Supplementary Forecast 2019-2025
9.3 Over the Counter (OTC) & Diet Supplementary Market Trend (Product Type)
9.4 Over the Counter (OTC) & Diet Supplementary Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Over the Counter (OTC) & Diet Supplementary Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



【掲載企業】

Bayer AG、Merck KGaA、Novartis、Johnson & Johnson、GlaxoSmithKline、Alkem Laboratories、Teva Pharmaceutical Industries、Pfizer、Sun Pharma、Allergan

★調査レポート[世界の店頭(OTC)及びダイエット補助食品市場 2019年] (コード:QYR20FB04213)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の店頭(OTC)及びダイエット補助食品市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆